Cyclin E2 Antikörper

Produktnummer ABIN7008605

Produktdetails anti-Cyclin E2 Antikörper

Target: Cyclin E2 (CCNE2)

Reaktivität: Human, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Cyclin E2 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC), Immunofluorescence (IF)

Produktmerkmale: Polyclonal Antibody

Aufreinigung: Affinity purification

Immunogen: Recombinant fusion protein of human CCNE2 (NP_477097.1).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC 1:50-1:200 IF 1:50-1:200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu Cyclin E2

Target: Cyclin E2 (CCNE2)

Andere Bezeichnung: CCNE2 (CCNE2 Produkte)

Synonyme: ccne2 antikoerper, MGC53684 antikoerper, MGC132360 antikoerper, cb165 antikoerper, sb:cb165 antikoerper, zgc:86724 antikoerper, CCNE2 antikoerper, cyce2 antikoerper, CYCE2 antikoerper, cyclin E2 antikoerper, cyclin E2 L homeolog antikoerper, cyclin E1 L homeolog antikoerper, CCNE2 antikoerper, ccne2.L antikoerper, ccne2 antikoerper, ccne1.L antikoerper, Ccne2 antikoerper

Hintergrund: The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK2. This cyclin has been shown to specifically interact with CIP/KIP family of CDK inhibitors, and plays a role in cell cycle G1/S transition. The expression of this gene peaks at the G1-S phase and exhibits a pattern of tissue specificity distinct from that of cyclin E1. A significantly increased expression level of this gene was observed in tumor-derived cells.

Gen-ID: 9134

UniProt: O96020

Pathways: Zellzyklus, Mitotic G1-G1/S Phases